How the discovery of new white blood cell subtypes can improve our understanding of lung disease progression in adult CF patients?
The effects of Trikafta/Kaftrio on people with CF who have mutations other than the most common CF mutation (F508del)
A step forward in the development of a safe anti-inflammatory molecule for the chronic respiratory disease of people with CF
Early acquisition and conversion of Pseudomonas aeruginosa in Hispanic youth with cystic fibrosis in the United States
